Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04766463Phase 3Completed
A Phase 3 trial of tegileridine in acute postoperative pain, sponsored by Hengrui. Started Mar 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04766463.